A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain (QoLMMBuS)
Observational Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain
Sponsor: Celgene
This observational or N/A phase trial investigates Multiple Myeloma and is currently completed. Celgene leads this study, which shows 14 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2021 — Dec 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
Mar 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Recruiting
-
May 2019 — Mar 2020 [monthly]
Recruiting
-
Aug 2018 — May 2019 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Celgene
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Algeciras, Spain , Alzira, Spain , Antequera, Spain , Barcelona, Spain , Bilbao, Spain , Burgos, Spain , Castellon, Spain , Córdoba, Spain , Getafe, Spain and 35 more locations